by Annie De Groot | Feb 26, 2019 | Events
2nd Antigen-Specific Immune Tolerance Drug Development Summit Tuesday, March 26th – Thursday, March 28th, 2019 Wyndham Boston Beacon Hill 5 Blossom Street Boston, Massachusetts 02114 USA Join Dr. Annie De Groot, CEO/CSO EpiVax, at the 2nd Antigen-Specific Immune...
by Sarah Moniz | Dec 19, 2017 | News, Thinking Out Loud -Blog
It all started in 2008, when Drs. Leslie and Annie De Groot, father and daughter, applied for a joint SBIR. Using their combined knowledge, as world leading endocrinologist and immunologist, they set out to develop a new way to treat Graves’ disease, an...
by Annie De Groot | Aug 25, 2017 | Events, Featured
[Updated] View Event Photos! The Westin Immunogenicity Seminar is a unique forum for industry and academic professionals to share ideas, present research updates and network with potential collaborators. The purpose of this seminar is to bridge the gap...
by Annie De Groot | Dec 22, 2014 | News
EpiVax Inc. enters license agreement with Novozymes Biopharma to advance pioneering treatment of autoimmune diseases Novozymes’ Veltis® albumin-based half-life extension platform will help move Tregitope treatment for autoimmune diseases closer to clinical...
by Annie De Groot | Mar 26, 2014 | Events, Thinking Out Loud -Blog
The 9th International Congress on Autoimmunity has kicked off! We are looking forwards to the presentations over the next 5 days, sure to be insightful and innovative. If you haven’t heard EpiVax is hosting Tregitope Nice – a scientific symposium entitled...
